Immerse yourself in a comprehensive, full-day virtual program on Clinical Updates on Sleep Disorders, led by Dr. Karl Doghramji, Program Director for the Fellowship in Sleep Medicine and Medical Director of the Jefferson Sleep Disorders Center. This event features a range of topics presented by leading experts in the field, offering the latest insights and advancements in sleep medicine. Attendees will have the opportunity to engage in live discussions with the experts and gain valuable knowledge.

The program will explore the newest developments in treating insomnia, with a focus on emerging hypnotic medications. It will also cover parasomnias, shedding light on unusual nighttime behaviors, and examine the relationship between psychiatric disorders and sleep, including the causes and effects on overall health.

Additional sessions will address sleep-related movement disorders, such as Restless Legs Syndrome, and the application of cognitive behavioral therapy as a non-pharmacological treatment for insomnia. The event will also include a discussion on pediatric sleep, distinguishing between typical and atypical sleep patterns in children.

Format

Live Virtual Event

Note: this event is ONLY available to view live on October 2, 2024 from 8:30 AM - 5:00 PM Eastern Standard Time.

Learning Objectives:

• Outline the prevalence and impact of insomnia in clinical settings
• Understand an evidence-based approach for the detection and evaluation of insomnia
• Construct individualized treatment plans for insomnia patients that consider safety concerns and individual patient and disease characteristics
• Understand the cardinal features of parasomnias in adults.
• Discuss the management of parasomnias in adults.
• Discuss how REM sleep behavior disorder is a common harbinger of future neurodegeneration in adults aged 50 years and older
• Explain the 4P model of the development of chronic insomnia.
• List the primary therapeutic components of cognitive-behavioral therapy for insomnia.
• Discuss the efficacy and benefits of delivering cognitive-behavioral therapy for insomnia fully-automated by the internet.

References

Perlis, Michael L ; Posner, Donn ; Riemann, Dieter ; Bastien, Celyne H ; Teel, Joseph ; Thase, Michael. The Lancet (British edition), 2022-09, Vol.400 (10357), p.1047-106

Sutton, Eliza L. Annals of internal medicine, 2021-03, Vol.174 (3), p.ITC33-ITC48 Veeravigrom, Montida ; Chonchaiya, Weerasak. Sleep medicine clinics, 2022-03, Vol.17 (1), p.67-76

McCrae, Christina S. ; Curtis, Ashley F. ; Stearns, Melanie A. Advances in psychiatry and behavioral health, 2024-09, Vol.4 (1), p.235-248

Irfan M, Schenck CH, Howell MJ. NonREM Disorders of Arousal and Related Parasomnias: an Updated Review. Neurotherapeutics. 2021;18(1):124-139.

Schenck CH. REM Sleep Behavior Disorder as a Complex Condition with Heterogeneous Underlying Disorders: Clinical Management and Prognostic Implications. Sleep and Breathing 2022; doi:10.1007/s11325-022-02574-6.

Schenck CH. Two Cases of Sleep-Related Dissociative Disorder with Episodes of Nocturnal Eating . Sleep Science 2024; doi: 10.1055/s-0044-1780498.

Target Audience

Psychiatrists

Instructional Level

Introductory/Intermediate

Estimate Time to Complete 

Estimated Duration: 7.0 hours (excluding breaks)
Program Start Date: October 2, 2024 
Program End Date: October 2, 2024 

Credit must be claimed by January 1, 2025.

Schedule:

How to Earn Credit 

Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by viewing the live presentation and completing the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (other disciplines) showing the event date and hours earned. 

Continuing Education Credit 

In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Physicians 

The APA designates this live event for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Faculty and Planner Disclosures 

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. 

Instructors 

• Karl Doghramji, MD. Reports financial relationships with Jazz, Harmony, Blogen, Idorsia, Janssen, Axsome, Merck, Inspire, Sommetrics, Nyxoah, and Respicardia.
• Carlos Schenck, MD 
• Argelinda Baroni, MD  
• Kelly Shaffer, PhD  
• John Winkelman, MD, PhD  
• Ruth Benca, MD 
• Jess Shatkin, MD, MPH 

Planners  

• Vishal Madaan, MD, APA Deputy Medical Director, Reports no financial relationships with commercial interests. 
• Karl Doghramji, MD. Reports financial relationships with Jazz, Harmony, Blogen, Idorsia, Janssen, Axsome, Merck, Inspire, Sommetrics, Nyxoah, and Respicardia.

Accessibility for Participants with Disabilities 

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar. 

Technical Requirements 

This internet-based CME activity is best experienced using any of the following: 

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari 
• Internet Explorer 11+ 

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player. 

Optimal System Configuration: 

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version) 
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version) 
• Internet Connection: 1 Mbps or higher 

Minimum Requirements: 

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content 
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content